¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"indirect acting bilirubin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® bilirubin ÇÑ±Û ºô¸®·çºó
¼³¸í   
  ´ãÁóÀÇ ÁÖ¼ººÐÀ¸·Î¼­ Ç÷»ö¼Ò¿¡¼­ À¯·¡ÇÏÁö¸¸ Ã¶À» Æ÷ÇÔÇÏÁö´Â ¾Ê´Â´Ù. »ý¼ºµÇ´Â °÷Àº ÁַΠÁö¶ó, °ñ¼ö µîÀÇ ¸Á³»°è·Î, ºô¸®º£¸£µòÀ» °ÅÃÄ À¯¸®ÇüÀÇ ºô¸®·çºóÀ¸·Î¼­ Ç÷ÁßÀ¸·Î ¹æÃâµÈ´Ù. 85%´Â ³ëÈ­ ÀûÇ÷±¸ÀÇ Ç÷»ö¼Ò¿¡¼­ À¯·¡ÇÑ´Ù. À¯¸®Çü ºô¸®·çºóÀº ¹°¿¡ ³ìÁö ¾Ê´Â´Ù. Ç÷Áß¿¡¼­´Â ¾ËºÎ¹Î°ú °áÇÕÇØ ÀÖÀ¸¸ç ÄáÆÏ¿¡¼­ ¹è¼³µÇÁö ¾ÊÀ¸¸ç, ¶Ç ½Å°æÁ¶Á÷À¸·ÎÀǠģȭ¼ºÀÌ Ä¿ ¾ËºÎ¹Î°ú °áÇÕÇÏÁö ¾ÊÀº °ÍÀº ½Å°æµ¶¼ºÀ» °®´Â´Ù. ¸ðµç Á¶Á÷°ú Ã¼¾×¿¡ ºÐÆ÷Çϸç, °£°ú ÄáÆÏ¿¡¼­ ºô¸®·çºó Ä§ÂøÀÌ ÇöÀúÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´(Áõ)
  • bilirubin glucuronide
    ºô¸®·çºó±Û·çÄí·Î´Ïµå
  • conjugate bilirubin
    °áÇÕºô¸®·çºó
  • conjugated bilirubin
    °áÇÕºô¸®·çºó
  • direct bilirubin
    Á÷Á¢ºô¸®·çºó
  • unconjugated bilirubin
    ºñ°áÇÕºô¸®·çºó
  • acting
    ÀÛ¿ë-
  • centrally acting muscle relaxant
    ÁßÃßÀÛ¿ë±ÙÀÌ¿ÏÁ¦, ÁßÃßÀÛ¿ë±ÙÀ°Ç®¸²Á¦
  • fast-acting insulin
    ±Þ¼ÓÀÛ¿ëÀν¶¸°
  • intermediate-acting insulin
    Áß°£ÀÛ¿ëÀν¶¸°
  • long acting
    Àå½Ã°£ÀÛ¿ë-, Áö¼Ó¼º-
  • long acting insulin
    Áö¼ÓÀÛ¿ëÀν¶¸°
  • long-acting thyroid stimulator
    Áö¼Ó°©»ó»ùÀڱع°Áú, Áö¼Ó°©»ó¼±Àڱع°Áú
  • short acting insulin
    ´Ü±âÀÛ¿ëÀν¶¸°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó
  • conjugated bilirubin
    °áÇÕºô¸®·çºó
  • unconjugated bilirubin
    ºñ°áÇÕºô¸®·çºó
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó
  • bilirubin glucuronide
    ºô¸®·çºó±Û·çÄí·Î´Ïµå
  • bilirubin encephalopathy
    ºô¸®·çºó³úº´Áõ
  • conjugate bilirubin
    °áÇÕºô¸®·çºó
  • direct bilirubin
    Á÷Á¢Çüºô¸®·çºó
  • unconjugate bilirubin
    ºñ°áÇÕºô¸®·çºó
  • acting
    ÀÛ¿ë-
  • centrally acting muscle relaxant
    ÁßÃßÀÛ¿ë±ÙÀ°Ç®¸²Á¦, ÁßÃßÀÛ¿ë±ÙÀ°ÀÌ¿ÏÁ¦
  • cognitive-acting drug
    ÀÎÁö±â´ÉȰ¼ºÁ¦
  • long acting insulin
    Áö¼ÓÀν¶¸°
  • short acting insulin
    ´Ü±âÀÛ¿ëÀν¶¸°
  • long acting
    Àå½Ã°£ÀÛ¿ë-, Áö¼Ó¼º-
  • long-acting thyroid stimulator
    Áö¼Ó¹æÆÐ»ùÀڱع°Áú, Áö¼Ó°©»ó»ùÀڱع°Áú
  • indirect adjustment
    °£Á¢º¸Á¤
  • indirect latex agglutination
    °£Á¢¶óÅØ½ºÀÀÁý¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • indirect bilirubin
    °£Á¢Çü(ÊàïÈúþ)ºô¸®·çºó.
  • LATS =long acting thyroid stimulator
    Áö¼Ó¼º °©»ó¼±Àڱع°Áú.
  • LATS=long acting thyroid stimulator
    Áö¼Ó¼º °©»ó¼± Àڱع°Áú.
  • acting out
    Çൿȭ ³ëÃâ .
  • agglutination, indirect
    °£Á¢ÀÀÁý¹ý
  • antiglobulin test, indirect
    °£Á¢Çױ۷κҸ° °Ë»ç
  • hemagglutination, indirect
    °£Á¢Ç÷±¸ÀÀÁý¹ý
  • indirect
    °£Á¢
  • indirect Coombs test
    °£Á¢Äñ½º°Ë»ç
  • indirect action
    °£Á¢ÀÛ¿ë.
  • indirect action
    °£Á¢ÀÛ¿ë
  • indirect agglutination
    °£Á¢ÀÀÁý(¹ÝÀÀ).
  • indirect analysis
    °£Á¢ºÐ¼®.
  • indirect antiglobulin test
    °£Á¢Çױ۷κҸ°°Ë»ç
  • indirect antiglobulin test
    °£Á¢Çױ۷κҸ°½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • indirect bilirubin
    °£Á¢Çü(ÊàïÈúþ)ºô¸®·çºó.
  • bilirubin
    ºô¸®·çºó
  • bilirubin
    ºô¸®·çºó
  • bilirubin glucuronide
    ºô¸®·çºó±Û·çÄí·Î´Ïµå
  • bilirubin metabolism
    ºô¸®·çºó´ë»ç(¡­ÓÛÞó).
  • bilirubin(a)emia
    ºô¸®·çºóÇ÷Áõ(¡­Ç÷Áõ).
  • bilirubin(a)emia
    ºô¸®·çºóÇ÷Áõ(¡­úìñø).
  • delta bilirubin
    µ¨Å¸ºô¸®·çºó
  • acting out
    Çൿȭ ³ëÃâ .
  • centrally acting muscle relaxant
    ÁßÃß¼º (ÀÛ¿ë)±ÙÀ°ÀÌ¿ÏÁ¦.
  • cognitive-acting drug(=enhancer)
    ÀÎÁö±â´ÉȰ¼ºÁ¦(ìãò±Ñ¦ÒöüÀàõð¥)
  • intermediate acting
    Á߽ð£Àۿ뼺(ñéãÁÊàíÂéÄàõ)ÀÇ, Áß°£Àۿ뼺ÀÇ.
  • long acting
    Àå½Ã°£ÀÛ¿ë(íþãÁÊàíÂéÄ)ÀÇ, Áö¼Ó¼ºÀÇ.
  • long acting drug
    Áö¼Ó¼º¾à(ò¥áÙàõå·).
  • long acting insulin
    Áö¼Ó¼º Àν¶¸°.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • indirect acting bilirubin
    °£Á¢ÀÛ¿ë(ÊàïÈíÂéÄ) ºô¸®·çºó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • direct-acting bilirubin
    Á÷Á¢¹ÝÀÀ(òÁïÈÚãëë) ºô¸®·çºó
  • bilirubin
    ºô¸®·çºó
  • bilirubin diglucuronide
    ÀÌ(ì£)±Û·çÅ¥·Ð»ê(ß«) ºô¸®·çºó
  • cis-acting locus
    ½Ã½ºÀÛ¿ë ºÎÀ§(íÂéÄÝ»êÈ)
  • long-acting thyroid stimulator
    Áö¼Ó¼º(ò¥áÙàõ) °©»ó¼±ÀÚ±ØÁ¦(Ë£ßÒàÍí©Ð½ð­)
  • trans-acting locus
    Æ®¶õ½ºÀÛ¿ëºÎÀ§ (íÂéÄÝ»êÈ)
  • indirect calorimetry
    °£Á¢¿­·®ÃøÁ¤¹ý(ÊàïÈæðÕáö°ïÒÛö)
  • indirect complement fixation test
    °£Á¢º¸Ã¼°íÁ¤½ÃÇè(ÊàïÈÜÍô÷ͳïÒãËúÐ)
  • indirect Coomb's test
    °£Á¢(ÊàïÈ) Äñ½ÃÇè(ãËúÐ)
  • indirect coupling
    °£Á¢(ÊàïÈ) ¦Áþ±â
  • indirect fluoresccnt antibody technique
    °£Á¢ Çü±¤Ç×ü¼ú(ÊàïÈû«ÎÃù÷ô÷âú)
  • indirect induction
    °£Á¢À¯µµ(ÊàïÈë¯Óô)
  • indirect mutagenesis
    °£Á¢º¯ÀÌÀ¯¹ß(ÊàïÈܨì¶ë¯Û¡)
  • indirect photoreactivation
    "°£Á¢ ±¤ÀçȰ¼ºÈ­(ÊàïÈÎÃî¢üÀàõûù), °£Á¢ ±¤È¸º¹(ÊàïÈÎÃüÞÜÖ)"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó
  • short acting
    ´Ü±âÀÛ¿ë
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Hb Hemoglobin; Ç÷»ö¼Ò; 13 - 15 mg%
  1 gm ÆÄ±«½Ã Indirect Bilirubin 40 mg Áõ°¡
  = ...
IFA idiopathic fibrosing alveolitis; immunofluorescence assay; immunofluorescent antibody; incomplete Fr...
IHA idiopathic hyperaldosteronism; indirect hemagglutination; indirect hemagglutination antibody
LATS Long-Acting Thyroid Stimulating hormone(= Stimulator)
LA lactic acid; large amount; laser angioplasty; late abortion; late antigen; latex agglutination; left...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LAN Long Acting Neuroleptic
LATS Long Acting Thyroid Stimulator
SAARD Slow Acting Anti-Rheumatic Drugs
L.A. long acting
BR Bilirubin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bilirubin
    ºô¸®·çºó
    1. ´ãÁó ±¸¼º ¼ººÐ Áß Çϳª·Î Ç÷»ö¼Ò ºÐÇØ »ê¹°·ÎºÎÅÍ ¸¸µé¾îÁø´Ù. ¼ö¸íÀÌ ´ÙÇÑ ÀûÇ÷±¸´Â ¼¼¸Á³»Çǰ迡¼­ ÆÄ±«µÇÁö¸¸ Çì¸ð±Û·ÎºóÀÇ ÇðÀº ºô¸®º£¸£µòÀÌ µÈ´Ù. ÇǺÎ, °¢¸· ¹× Á¡¸· µî¿¡ ÃàÀûµÇ¸é Ȳ´ÞÀ» ÀÏÀ¸Å²´Ù. 2. ´ë½Ä ¼¼Æ÷³»¿¡¼­ Ç÷»ö¼Ò°¡ ºÐÇØµÇ¾î »ý¼ºµÇ´Â ´ãÁó »ö¼Ò·Î Ç÷¾×³»¿¡¼­ ¾ËºÎ¹Î°ú °áÇÕÇÏ¿© °£À» °ÅÃÄ °á±¹ ´ãÁóÀ» Çü¼ºÇÏ°Ô µÈ´Ù. ¶ÇÇÑ ÀÌ »ö¼Ò´Â Ç÷ÁßÀ̳ª ÇǺΠ°¢¸· ¹× Á¡¸·¿¡ ÃàÀûÀÌ µÇ±âµµ ÇÑ´Ù. 3. Çì¸ð±Û·Îºó ÆÄ±«¿¡ ÀÇÇÑ ³ëÆó¹°ÀÇ »ö¼Ò.
  • bilirubin test
    ºô¸®·çºó ½ÃÇè
  • conjugated bilirubin
    °áÇÕÇü ºô¸®·çºó
  • centrally acting muscle relaxant
    ÁßÃß¼º ±ÙÀ° ÀÌ¿ÏÁ¦
  • long acting drug
    Áö¼Ó¼º ¾à
  • long acting sulfonamide
    Áö¼Ó¼º ¼³ÆÄÁ¦
  • long-acting nitrates
    Àå½Ã°£ ÀÛ¿ëÇÏ´Â Áú»ê¿°
  • short acting insulin
    ¼ÓÈ¿¼º Àν¶¸°
  • indirect
    °£Á¢
    Áï½Ã ¶Ç´Â ¹Ù·Î°¡ ¾Æ´Ñ. Áß°£ ¾àÀ縦 ÅëÇØ ÀÛ¿ëÇÏ´Â.
  • indirect agglutination
    °£Á¢ ÀÀÁý¹ý
  • indirect effect
    °£Á¢ È¿°ú
  • indirect hemagglutination
    °£Á¢ Ç÷±¸ ÀÀÁý ¹ÝÀÀ
    ¼öµ¿ÀûÀ¸·Î Ç¥¸é¿¡ ÈíÂø½ÃŰ°Å³ª ¼¼Æ÷¿¡ È­ÇÐÀûÀ¸·Î °áÇÕ½ÃŲ Ç׿ø°ú ƯÀÌÇ×ü »çÀÌÀÇ ¹ÝÀÀ¿¡ ÀÇÇÑ ÀûÇ÷±¸ÀÇ ÀÀÁý.
  • indirect method
    °£Á¢¹ý
    䵿ÇÑ Àλ󿡼­ Á¦ÀÛµÈ ¸ðÇü»ó¿¡¼­ Ä¡°ü ¼öº¹¹°À» Á¦ÀÛÇÏ´Â ¹æ¹ý.
  • indirect pulp capping
    °£Á¢ Ä¡¼ö º¹Á¶¹ý
    »ì±Õ¼º, ÁøÅ뼺, º¸È£¼º ¹°ÁúÀ» Ä¡¼ö°¡ ³ëÃâµÇ±â Á÷ÀüÀÇ ¾ãÀº Ä¡Áú¿¡ µ¤¾î ¾º¿ì´Â °Í.
  • indirect pulp therapy
    °£Á¢ Ä¡¼ö Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
indirect bilirubin <biochemistry> Free bilirubin that has not been attached to a glucuronide molecule. This results from the rapid breakdown of red blood cells. The haemoglobin molecule is normally converted to bilirubin. Greater than normal values of indirect bilirubin can be seen in erythroblastosis foetalis, haemolytic anaemia, sickle cell anaemia, transfusion reactions, pernicious anaemia and resolution of large haematomas.
(27 Sep 1997)
indirect reacting bilirubin The fraction of serum bilirubin which has not been conjugated with glucuronic acid in the liver cell; so called because it reacts with the Ehrlich diazo reagent only when alcohol is added; increased levels are found in hepatic disease and haemolytic conditions.
Synonym: unconjugated bilirubin.
(05 Mar 2000)
acting out Expressing unconscious emotional conflicts or feelings, often of hostility or love, through overt behaviour.
(12 Dec 1998)
cis acting <molecular biology> Having to do with a genetic element (such as a promoter or other regulatory locus) having an effect (like promotion or suppression) on two unrelated targets (such as genes) on the same chromosome as a result of their relative positions on the chromosome.
A gene which regulates the transcription into mRNA of other genes nearby on the same chromosome by binding protein transcription factors which are necessary to turn transcription on or off.
(09 Oct 1997)
cis-acting locus A section of DNA that affects the activity of DNA sequences on that same molecule of DNA.
(05 Mar 2000)
cis-acting protein A protein that acts on the molecule of DNA from which it was expressed.
(05 Mar 2000)
self-acting Acting of or by one's self or by itself; said especially of a machine or mechanism which is made to perform of or for itself what is usually done by human agency; automatic; as, a self-acting feed apparatus; a self-acting mule; a self-acting press.
Source: Websters Dictionary
(01 Mar 1998)
long-acting thyroid stimulator <endocrinology, immunology> A thyroid stimulating antibody which is directed against a receptor for TSH on the thyroid gland.
This antibody acts like TSH and stimulates the thyroid to produce excessive amounts of thyroid hormone. The presence of this antibody generally indicates Grave's disease (hyperthyroidism).
Acronym: LATS
(15 Nov 1997)
bilirubin <biochemistry> A pigment produced when the liver processes waste products. A high bilirubin level causes yellowing of the skin.
(16 Dec 1997)
bilirubin encephalopathy <paediatrics> Disorder due to jaundice in a newborn baby with high blood levels of the pigment bilirubin that is deposited in the brain resulting in damage. The level of bilirubin is monitored in newborns to determine whether treatment is needed to prevent kernicterus. With brain affected, it is also called bilirubin encephalopathy.
(12 Dec 1998)
bilirubin glucuronoside glucuronosyltransferase <enzyme> Conjugates one or two glucuronic acid molecules to the carboxyl groups of the propionate side chains of bilirubin thereby removing free bilirubin from the body; ugt1.4 is the minor human bilirubin udp-glucuronosyltransferase (ugt)
Registry number: EC 2.4.1.95
Synonym: bilirubin glucuronyl transferase, bilirubin glucuronyltransferase, bilirubin udp-glucuronosyltransferase, ugt1.4
(26 Jun 1999)
bilirubin monoglucuronide transglucuronidase <enzyme> Is a transferase that transfers a glucuronoside from one molecule of bilirubin glucuronoside to another, forming bilirubin bisglucuronoside and unconjugated bilirubin. A step in haem catabolism.
(05 May 2002)
bilirubin UDP-glucuronyltransferase <enzyme> An enzyme that catalyses the reaction of UDP-glucuronate and bilirubin forming UDP and bilirubin-glucuronoside; a deficiency of this enzyme is associated with Crigler-Najjar syndrome.
(05 Mar 2000)
conjugated bilirubin Conjugated bilirubin = Direct bilirubin. Bilirubin that has been chemically attached to a glucuronide in the liver. The bilirubin that is excreted into the bile by the liver and stored in the gallbladder or transferred to the duodenum. Normal direct bilirubin is 0 to 0.3 mg/dl. Greater than normal values can be seen in bile duct obstruction, cirrhosis, Crigler-Najjar syndrome, Dubin-Johnson syndrome and hepatitis.
(27 Sep 1997)
delta bilirubin The fraction of bilirubin covalently bound to albumin; in conventional methods it is measured as part of conjugated bilirubin. Because of its covalent bond during the recovery phase of hepatocellular jaundice, it may persist in the blood for a week or more after urine clears.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilirubin
    ºô¸®·çºó(´ãÁó¼ÓÀÇ ÀûȲ»ö »ö¼Ò)
  • acting
    ´ë¸®ÀÇ
  • acting
    ´ë¸®ÀÇ
  • acting
    ¿¬±â;¿¬Ãâ
  • ensemble acting (playing)
    ¾Ó»óºí ¿¬Ãâ(½ºÅ¸ Áß½ÉÀÌ ¾Æ´Ñ Àüü ¹è¿ìÀÇ Á¾ÇÕÀû È¿°ú¸¦ ³ë¸®´Â)
  • indirect
    ¶È¹Ù¸£Áö ¾ÊÀº
  • indirect
    (opp.direct);(±æµî)¶È¹Ù¸£Áö ¾ÊÀº;¿ìȸÇÏ´Â;(¸»µî)ºùµÑ·¯´ë´Â;¿¡µÎ¸¥;°£Á¢ÀÇ;°£Á¢ÀûÀÎ;ÀÌÂ÷ÀûÀÎ;¹æ°èÀÇ(secondary);¼ÖÁ÷ÇÏÁö ¾ÊÀº;Á¤Á÷ÇÏÁö ¾ÊÀº;(¹®¹ý)°£Á¢È­¹ýÀÇ
  • indirect aggression
    (´ë¿Ü)¹æ¼ÛÀü;¼±Àü;°£Á¢Ä§·«;ºñ±º»çÀû °ø°Ý
  • indirect cost
    (°æ)°£Á¢ºñ;ÀϹݺñ¿ë
  • indirect discourse
    (¹®¹ý)°£Á¢È­¹ý À½
  • indirect fire
    (±º)°£Á¢ Á¶ÁØ»ç°Ý
  • indirect lighting
    °£Á¢Á¶¸í
  • indirect narration
    INDIRECT DISCOURSE
  • indirect object
    (¹®¹ý)°£Á¢ ¸ñÀû¾î
  • indirect primary
    (¹Ì)°£Á¢ ¿¹ºñ ¼±°Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á